Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Orion OyjORINF 100 EV-to-OCF is 24.30 as of Aug. 07, 2026, which is 13% above its 10-year median of 21.42. GuruFocus rates ORINF with a GF Score™ of 100/100 and a GF Value™ of $77.19. The stock has 4 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Orion Oyj ranks worse than 72.69% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Orion Oyj's Enterprise Value is $13,287 Mil.
Orion Oyj's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $547 Mil. Therefore, Orion Oyj's EV-to-OCF for today is 24.30.
The historical rank and industry rank for Orion Oyj's EV-to-OCF or its related term are showing as below:
ORINF'
s EV-to-OCF Range Over the Past 10 Years
Min: 11.25 Med: 21.42 Max: 74.43
Current: 23.44
During the past 13 years, the highest EV-to-OCF of Orion Oyj was 74.43. The lowest was 11.25. And the median was 21.42.
ORINF's EV-to-OCF is ranked worse than 72.69% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 10.87
vs ORINF: 23.44
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Orion Oyj's share price for today is $82.75.
Orion Oyj's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.856.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Orion Oyj EV-to-OCF Related Terms
Orion Oyj EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Orion Oyj's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Orion Oyj's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Oyj EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Orion Oyj's EV-to-OCF falls into.
Orion Oyj's current Enterprise Value is $13,287 Mil.
Orion Oyj's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $547 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Oyj (ORINF) has a EV-to-OCF of 24.30 as of Aug. 07, 2026. This is 13% above median its historical median of 21.42. Over the past decade, Orion Oyj's EV-to-OCF has ranged from 11.25 to 74.43. According to the industry distribution chart, Orion Oyj ranks #732 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 72.7%.
Is Orion Oyj's EV-to-OCF too high?
Orion Oyj's current EV-to-OCF of 24.30 is 13% above median its 10-year median of 21.42. Over the past 10 years, this metric has ranged from a low of 11.25 to a high of 74.43. The Drug Manufacturers industry median EV-to-OCF is 10.87. Orion Oyj's value of 24.30 is 123.6% above this industry median. Based on the distribution chart, Orion Oyj ranks #732 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Orion Oyj has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's EV-to-OCF compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Orion Oyj ranks #732 out of 1007 companies for EV-to-OCF. This places Orion Oyj in the lower half of its industry. The industry median EV-to-OCF is 10.87. Orion Oyj's value of 24.30 is 123.6% above this benchmark. Historically, Orion Oyj's own EV-to-OCF has ranged from 11.25 to 74.43 over the past decade. While the company's 10-year median is 21.42 vs. the industry median of 10.87, Orion Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.87, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Oyj's current EV-to-OCF of 24.30 is 123.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Oyj's current EV-to-OCF is 24.30, which is 13% above median its own 10-year median of 21.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Orion Oyj (ORINF) has a current EV-to-OCF of 24.30. The stock's GF Value™ is $77.19, compared to a current price of $82.75 — trading 7.2% above its estimated fair value. The current EV-to-OCF is 24.30, which is 13% above median its 10-year median of 21.42 and 123.6% above the Drug Manufacturers industry median of 10.87. Orion Oyj's overall GF Score™ is 100/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Orion Oyj (ORINF), the current EV-to-OCF is 24.30 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Oyj (ORINF) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Oyj stock appears to be overvalued.
The current stock price of $82.75 is trading 7.2% above its estimated GF Value™ of $77.19.
Key valuation signals for ORINF:
EV-to-OCF: 24.30 (13% above median its 10-year median of 21.42)
GF Value™: $77.19 vs. price of $82.75 (7.2% above fair value)
Industry Position: 123.6% above the Drug Manufacturers median (#732 of 1007)
No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
100GF Score
Get the complete analysis for ORINF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORINF has been successfully added to your 
